{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:31:08Z","timestamp":1792513868303,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Scientific Grant Agency of the M\u0160VVa\u0160 and the SAV","doi-asserted-by":"publisher","award":["2\/0099\/23"],"award-info":[{"award-number":["2\/0099\/23"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-22\\u20130341"],"award-info":[{"award-number":["APVV-22\\u20130341"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["313011V344 - OBEZITA"],"award-info":[{"award-number":["313011V344 - OBEZITA"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118715","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:06:14Z","timestamp":1761822374000},"page":"118715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Fuelling resistance: Lipid metabolic rewiring in cancer response to chemotherapy and radiotherapy"],"prefix":"10.1016","volume":"193","author":[{"given":"Viktoria","family":"Piatrikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kocianova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Skvarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-1478","authenticated-orcid":false,"given":"Tereza","family":"Golias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2025.118715_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbalip.2011.06.009","article-title":"Lipid classification, structures and tools","volume":"1811","author":"Fahy","year":"2011","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118715_bib2","article-title":"Targeted lipidomics analysis of possible molecular mechanisms of lipid changes in temporal lobe epilepsy models","volume":"15","author":"Sun","year":"2024","journal-title":"Front Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118715_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"issue":"12","key":"10.1016\/j.biopha.2025.118715_bib4","article-title":"Lipid metabolism and resistance to anticancer treatment","volume":"9","author":"Germain","year":"2020","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.biopha.2025.118715_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118095","article-title":"Lipid metabolism in cancer: exploring phospholipids as potential biomarkers","volume":"187","author":"Delmas","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40364-024-00681-y","article-title":"Roles of posttranslational modifications in lipid metabolism and cancer progression","volume":"12","author":"Feng","year":"2024","journal-title":"Biomark. Res"},{"issue":"20","key":"10.1016\/j.biopha.2025.118715_bib8","doi-asserted-by":"crossref","first-page":"R1212","DOI":"10.1016\/j.cub.2018.08.022","article-title":"Impact of mitochondrial fatty acid synthesis on mitochondrial biogenesis","volume":"28","author":"Nowinski","year":"2018","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2023.11.017","article-title":"Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism","volume":"36","author":"Wedan","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118715_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: an emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118715_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216352","article-title":"Fatty acids in cancer chemoresistance","volume":"572","author":"Qin","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biom14010064","article-title":"Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer","volume":"14","author":"Coradini","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1039\/D3SC04705A","article-title":"Monitoring the synthesis of neutral lipids in lipid droplets of living human cancer cells using two-color infrared photothermal microscopy","volume":"15","author":"Park","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2025.118715_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/112_2020_51","article-title":"Lipid droplets in cancer","volume":"185","author":"Petan","year":"2023","journal-title":"Rev. Physiol. Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118715_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: From cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog. Lipid Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/PN9.0000000000000068","article-title":"Radioresistance via lipid metabolism: intrinsic, acquired, and tumor microenvironment","volume":"3","author":"Su","year":"2024","journal-title":"Precis. Nutr."},{"issue":"12","key":"10.1016\/j.biopha.2025.118715_bib18","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/jcp.31137","article-title":"Stearoyl-CoA desaturase 1 inhibition impairs triacylglycerol accumulation and lipid droplet formation in colorectal cancer cells","volume":"238","author":"Tracz-Gaszewska","year":"2023","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.118715_bib19","unstructured":"GLOBOCAN International Agency for Research on Cancer Global Cancer Observatory; 2022\u3008https:\/\/gco.iarc.fr\/en\u3009(accessed June 17, 2025).."},{"key":"10.1016\/j.biopha.2025.118715_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7530794","article-title":"Radiotherapy\/chemotherapy-immunotherapy for cancer management: from mechanisms to clinical implications","volume":"2023","author":"Li","year":"2023","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2025.118715_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.875318","article-title":"Novel insights on lipid metabolism alterations in drug resistance in cancer","volume":"10","author":"Yang","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118715_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12032-023-02138-y","article-title":"Cancer chemoresistance and its mechanisms: associated molecular factors and its regulatory role","volume":"40","author":"Kannampuzha","year":"2023","journal-title":"Med Oncol."},{"issue":"17","key":"10.1016\/j.biopha.2025.118715_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179451","article-title":"Battling chemoresistance in cancer: root causes and strategies to uproot them","volume":"22","author":"Ramos","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mco2.55","article-title":"Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm (2020)"},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib25","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3892\/ol.2020.11769","article-title":"Implications of lipid droplets in lung cancer: associations with drug resistance","volume":"20","author":"Jin","year":"2020","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071850","article-title":"Modifications of plasma membrane organization in cancer cells for targeted therapy","volume":"26","author":"Choromanska","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1535-7163.MCT-07-0445","article-title":"A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction","volume":"7","author":"Liu","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118715_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.571237","article-title":"New insights into targeting membrane lipids for cancer therapy","volume":"8","author":"Preta","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118715_bib29","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: from threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12964-025-02090-6","article-title":"Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer","volume":"23","author":"Pulica","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"11","key":"10.1016\/j.biopha.2025.118715_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112362","article-title":"ABC transporters in cancer stem cells: beyond chemoresistance","volume":"18","author":"Begicevic","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/07315724.2011.10719969","article-title":"Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line","volume":"30","author":"Kuan","year":"2011","journal-title":"J. Am. Coll. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib33","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11010-020-03999-x","article-title":"Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma","volume":"476","author":"Rani","year":"2021","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.biopha.2025.118715_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102754","article-title":"Drug-induced oxidative stress in cancer treatments: angel or devil?","volume":"63","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7150\/ijbs.66602","article-title":"Enhanced intracellular reactive oxygen species by photodynamic therapy effectively promotes chemoresistant cell death","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118715_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","article-title":"Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells","volume":"1807","author":"Pike","year":"2011","journal-title":"Biochim Biophys. Acta"},{"issue":"12","key":"10.1016\/j.biopha.2025.118715_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121605","article-title":"The role of CD36 in cancer progression and its value as a therapeutic target","volume":"12","author":"Feng","year":"2023","journal-title":"Cells"},{"issue":"73","key":"10.1016\/j.biopha.2025.118715_bib38","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1039\/D0CC02174A","article-title":"Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36","volume":"56","author":"Jayawardhana","year":"2020","journal-title":"Chem. Commun. (Camb. )"},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib39","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1245\/s10434-019-07927-2","article-title":"Impact of CD36 on chemoresistance in pancreatic ductal adenocarcinoma","volume":"27","author":"Kubo","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2025.118715_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.879317","article-title":"Ferroptosis and tumor drug resistance: current status and major challenges","volume":"13","author":"Nie","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118715_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7674565","article-title":"TXNRD1: a key regulator involved in the ferroptosis of CML cells induced by cysteine depletion in vitro","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"issue":"20","key":"10.1016\/j.biopha.2025.118715_bib43","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","article-title":"De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation","volume":"70","author":"Rysman","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118715_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23081941","article-title":"Lipid droplets in cancer: guardians of fat in a stressful world","volume":"23","author":"Petan","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41467-017-02732-5","article-title":"Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance","volume":"9","author":"Cotte","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13046-019-1120-4","article-title":"Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer","volume":"38","author":"Huang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2015.09.020","article-title":"Antioxidant role for lipid droplets in a stem cell Niche of Drosophila","volume":"163","author":"Bailey","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2025.118715_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118715_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2014.07.054","article-title":"3beta-Acetyl tormentic acid reverts MRP1\/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity","volume":"741","author":"Rocha Gda","year":"2014","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118715_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1399065","article-title":"Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways","volume":"12","author":"Khan","year":"2024","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13046-022-02261-0","article-title":"Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling","volume":"41","author":"Yu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118715_bib53","first-page":"45","article-title":"Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity","author":"Cioce","year":"2024","journal-title":"Cancer Drug Resist 7"},{"key":"10.1016\/j.biopha.2025.118715_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.724149","article-title":"Cholesterol-lowering drugs on Akt signaling for prevention of tumorigenesis","volume":"12","author":"Kumar","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tibs.2017.11.004","article-title":"Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation","volume":"43","author":"Sivanand","year":"2018","journal-title":"Trends Biochem Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-024-01759-7","article-title":"Protein lipidation in health and disease: molecular basis, physiological function and pathological implication","volume":"9","author":"Yuan","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib57","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.chembiol.2018.05.003","article-title":"Protein lipidation in cell signaling and diseases: function, regulation, and therapeutic opportunities","volume":"25","author":"Chen","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41568-024-00666-x","article-title":"Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets","volume":"24","author":"Tate","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118715_bib59","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00018-020-03635-3","article-title":"Antioxidant functions of DHHC3 suppress anti-cancer drug activities","volume":"78","author":"Sharma","year":"2021","journal-title":"Cell Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib60","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/ijc.21570","article-title":"Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations","volume":"118","author":"Gyorffy","year":"2006","journal-title":"Int J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","article-title":"Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118715_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102031","article-title":"Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production","volume":"89","author":"Sharrow","year":"2024","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2025.118715_bib63","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","article-title":"Emerging targets in lipid metabolism for cancer therapy","volume":"45","author":"Terry","year":"2024","journal-title":"Trends Pharm. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118715_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2020.148300","article-title":"Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics","volume":"1861","author":"Salunkhe","year":"2020","journal-title":"Biochim Biophys. Acta Bioenerg."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41389-022-00420-8","article-title":"Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance","volume":"11","author":"Vasseur","year":"2022","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41389-025-00566-1","article-title":"Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistance","volume":"14","author":"Deswal","year":"2025","journal-title":"Oncogenesis"},{"key":"10.1016\/j.biopha.2025.118715_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.742374","article-title":"Targeting ACLY attenuates tumor growth and acquired cisplatin resistance in ovarian cancer by inhibiting the PI3K-AKT pathway and activating the AMPK-ROS pathway","volume":"11","author":"Wei","year":"2021","journal-title":"Front Oncol."},{"issue":"20","key":"10.1016\/j.biopha.2025.118715_bib68","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","article-title":"De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer","volume":"77","author":"Tadros","year":"2017","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.biopha.2025.118715_bib69","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118715_bib70","article-title":"Sesquiterpene alcohol cedrol chemosensitizes human cancer cells and suppresses cell proliferation by destabilizing plasma membrane lipid rafts","volume":"8","author":"Mishra","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41698-025-01090-6","article-title":"Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma","volume":"9","author":"Manas","year":"2025","journal-title":"NPJ Precis Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib72","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/jcp.29232","article-title":"Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin","volume":"235","author":"Zhang","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib73","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/jog.14779","article-title":"Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo","volume":"47","author":"Cheng","year":"2021","journal-title":"J. Obstet. Gynaecol. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib74","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system x(c)- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-018-0758-7","article-title":"Role of metabolism in cancer cell radioresistance and radiosensitization methods","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cells14010018","article-title":"Strategies to overcome intrinsic and acquired resistance to chemoradiotherapy in head and neck cancer","volume":"14","author":"de Bakker","year":"2024","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.biopha.2025.118715_bib79","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","article-title":"Tumour fatty acid metabolism in the context of therapy resistance and obesity","volume":"21","author":"Hoy","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118715_bib80","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijbs.79928","article-title":"Novel insight into metabolic reprogrammming in cancer radioresistance: a promising therapeutic target in radiotherapy","volume":"19","author":"Yu","year":"2023","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118715_bib81","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3389\/fonc.2019.01201","article-title":"CPT1A\/2-Mediated FAO enhancement-a metabolic target in radioresistant breast cancer","volume":"9","author":"Han","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118715_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/HP.S163115","article-title":"A novel approach to target hypoxic cancer cells via combining beta-oxidation inhibitor etomoxir with radiation","volume":"6","author":"Dheeraj","year":"2018","journal-title":"Hypoxia (Auckl. )"},{"issue":"9","key":"10.1016\/j.biopha.2025.118715_bib83","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.7150\/thno.21451","article-title":"Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy","volume":"8","author":"Tan","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118715_bib84","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72943","article-title":"Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance","volume":"10","author":"Tirinato","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13008-024-00116-y","article-title":"Cancer radioresistance is characterized by a differential lipid droplet content along the cell cycle","volume":"19","author":"Pagliari","year":"2024","journal-title":"Cell Div."},{"issue":"11","key":"10.1016\/j.biopha.2025.118715_bib86","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1039\/D3AN00121K","article-title":"Understanding radiation response and cell cycle variation in brain tumour cells using Raman spectroscopy","volume":"148","author":"Hill","year":"2023","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"16","author":"Lee","year":"2017","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib88","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","article-title":"Role of cell cycle in mediating sensitivity to radiotherapy","volume":"59","author":"Pawlik","year":"2004","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41419-023-05968-w","article-title":"Fatty acid oxidation facilitates DNA double-strand break repair by promoting PARP1 acetylation","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1115","key":"10.1016\/j.biopha.2025.118715_bib90","doi-asserted-by":"crossref","first-page":"20200067","DOI":"10.1259\/bjr.20200067","article-title":"Emerging strategies to target cancer metabolism and improve radiation therapy outcomes","volume":"93","author":"Kery","year":"2020","journal-title":"Br. J. Radio."},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib91","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/med.20117","article-title":"4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest","volume":"28","author":"Poli","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2025.118715_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.675617","article-title":"Fatty acids metabolism: the bridge between ferroptosis and ionizing radiation","volume":"9","author":"Yuan","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib93","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118715_bib94","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1007\/s12094-023-03134-4","article-title":"The role of lipid metabolism in cancer radioresistance","volume":"25","author":"An","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118715_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/nu17071262","article-title":"Soybean lecithin-gallic acid complex sensitizes lung cancer cells to radiation through ferroptosis regulated by Nrf2\/SLC7A11\/GPX4 pathway","volume":"17","author":"Chen","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118715_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102677","article-title":"Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis","volume":"62","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib97","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41419-025-07516-0","article-title":"Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3","volume":"16","author":"Cao","year":"2025","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118715_bib98","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s12276-025-01457-6","article-title":"Cholesterol biosynthesis induced by radiotherapy inhibits cGAS-STING activation and contributes to colorectal cancer treatment resistance","volume":"57","author":"Zhu","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib99","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","article-title":"Nuclear acetyl-CoA Production by ACLY promotes homologous recombination","volume":"67","author":"Sivanand","year":"2017","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.biopha.2025.118715_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121971","article-title":"ACLY (ATP Citrate Lyase) mediates radioresistance in head and neck squamous cell carcinomas and is a novel predictive radiotherapy biomarker","volume":"11","author":"Gottgens","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib101","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s13277-012-0605-y","article-title":"Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma","volume":"34","author":"Kao","year":"2013","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib102","first-page":"89","article-title":"Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers","volume":"2","author":"Yang","year":"2011","journal-title":"Int J. Biochem Mol. Biol."},{"issue":"45","key":"10.1016\/j.biopha.2025.118715_bib103","doi-asserted-by":"crossref","first-page":"E6965","DOI":"10.1073\/pnas.1609934113","article-title":"FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-kappaB and SP1","volume":"113","author":"Wu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49486-2","article-title":"Fatty acid inhibition sensitizes androgen-dependent and -independent prostate cancer to radiotherapy via FASN\/NF-kappaB pathway","volume":"9","author":"Chuang","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118715_bib105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bjc.2014.385","article-title":"Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation","volume":"111","author":"Souchek","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118715_bib106","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/2211-5463.13137","article-title":"SREBP1\/FASN\/cholesterol axis facilitates radioresistance in colorectal cancer","volume":"11","author":"Jin","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"11","key":"10.1016\/j.biopha.2025.118715_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt1241","article-title":"Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair","volume":"11","author":"Chiang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.118715_bib108","article-title":"Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance","author":"Lei","year":"2025","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.biopha.2025.118715_bib109","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","article-title":"Protein lipoylation: mitochondria, cuproptosis, and beyond","volume":"49","author":"Lin","year":"2024","journal-title":"Trends Biochem Sci."},{"issue":"6586","key":"10.1016\/j.biopha.2025.118715_bib110","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118715_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116247","article-title":"The effect of lipid metabolism on cuproptosis-inducing cancer therapy","volume":"172","author":"Zhong","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118715_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103772","article-title":"Disruption of FDPS\/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling","volume":"75","author":"Seshacharyulu","year":"2022","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib113","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1158\/1535-7163.MCT-17-0288","article-title":"HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation","volume":"17","author":"Efimova","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"18","key":"10.1016\/j.biopha.2025.118715_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810102","article-title":"Lipid droplet biosynthesis impairment through DGAT2 inhibition sensitizes MCF7 breast cancer cells to radiation","volume":"22","author":"Nistico","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118715_bib115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acschembio.9b00939","article-title":"Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers","volume":"15","author":"Ye","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118715_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212603","article-title":"Contribution of lipid oxidation and ferroptosis to radiotherapy efficacy","volume":"22","author":"Pearson","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118715_bib117","unstructured":"U.S. National Library of Medicine, ClinicalTrialsClinicalTrials.gov: Search results for Sorafenib. https:\/\/clinicaltrials.gov\/search?intr=Sorafenib, 2025, \u3008https:\/\/clinicaltrials.gov\/search?intr=Sorafenib\u3009(accessed June 17, 2025).."},{"key":"10.1016\/j.biopha.2025.118715_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103438","article-title":"RSL3 sensitizes glioma cells to ionizing radiation by suppressing TGM2-dependent DNA damage repair and epithelial-mesenchymal transition","volume":"78","author":"Wang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118715_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101018","article-title":"Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.annonc.a058177","article-title":"The antitumor activity of radiation therapy is reduced in patients with non-small-cell carcinoma of the lung refractory to chemotherapy","volume":"3","author":"Morita","year":"1992","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib121","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0167-8140(95)01696-1","article-title":"Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines","volume":"39","author":"Pauwels","year":"1996","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.biopha.2025.118715_bib122","article-title":"Editorial: chemo-radiation-resistance in cancer therapy","volume":"13","author":"Lin","year":"2022","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118715_bib123","first-page":"2110","article-title":"Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine","volume":"45","author":"Louie","year":"1985","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118715_bib124","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/oxfordjournals.annonc.a058173","article-title":"Cross resistance between radiotherapy and chemotherapy in cancer treatment: what can be done about it?","volume":"3","author":"Mirimanoff","year":"1992","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118715_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091224","article-title":"Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells","volume":"11","author":"Schmidtova","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib126","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acsomega.4c09353","article-title":"Modification-specific proteomic analysis reveals cysteine S-palmitoylation involved in esophageal cancer cell radiation","volume":"10","author":"Ni","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2025.118715_bib127","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002297","article-title":"Metabolic mechanisms of immunotherapy resistance","volume":"6","author":"Cabezon-Gutierrez","year":"2025","journal-title":"Explor Target Antitumor Ther."},{"issue":"11","key":"10.1016\/j.biopha.2025.118715_bib128","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41423-024-01224-z","article-title":"Regulation of CD8+ T cells by lipid metabolism in cancer progression","volume":"21","author":"Tang","year":"2024","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12944-023-01807-1","article-title":"Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy","volume":"22","author":"Qiao","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40364-024-00588-8","article-title":"Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy","volume":"12","author":"Shan","year":"2024","journal-title":"Biomark. Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118715_bib131","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118715_bib132","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2023.05.002","article-title":"Obesity-induced changes in cancer cells and their microenvironment: mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism","volume":"93","author":"Lee-Rueckert","year":"2023","journal-title":"Semin Cancer Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11010051","article-title":"L-carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine","volume":"11","author":"McCann","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.biopha.2025.118715_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23867","article-title":"The role of serum acylcarnitine profiling for the detection of multiple solid tumors in humans","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.biopha.2025.118715_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4922","article-title":"Identifying potential serum biomarkers of breast cancer through targeted free fatty acid profiles screening based on a GC-MS platform","volume":"34","author":"Tan","year":"2020","journal-title":"Biomed. Chromatogr."},{"issue":"7884","key":"10.1016\/j.biopha.2025.118715_bib136","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41586-021-04049-2","article-title":"Low glycaemic diets alter lipid metabolism to influence tumour growth","volume":"599","author":"Lien","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2025.118715_bib137","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ccell.2020.04.005","article-title":"Dietary approaches to cancer therapy","volume":"37","author":"Tajan","year":"2020","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.biopha.2025.118715_bib138","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-022-00485-y","article-title":"Developing dietary interventions as therapy for cancer","volume":"22","author":"Taylor","year":"2022","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:22:50Z","timestamp":1778541770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":138,"alternative-id":["S0753332225009096"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118715","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fuelling resistance: Lipid metabolic rewiring in cancer response to chemotherapy and radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118715"}}